——  NEWS CENTER  ——

What factory is rewriting the global health industry landscape?

What factory is rewriting the global health industry landscape? The answer lies in the quietly rising peptide factories. When small molecule peptides become the "new aristocrats of health" in the era of precision nutrition, peptide factories are using technological innovation as a pen to outline a new blueprint for the big health industry.

The core competitiveness of peptide factories stems from the ultimate pursuit of "absorption efficiency". Unlike the cumbersome digestion process of traditional nutritional products, the small molecule peptides produced here (with a molecular weight of less than 1000 daltons) can directly penetrate the small intestinal mucosa, with an absorption rate 20 times that of ordinary proteins, solving the problem of nutrient absorption from the root. Relying on core technologies such as directed enzyme digestion and precise purification, the peptide factory can efficiently extract active peptides with immune regulation, skin repair, metabolic management, and other functions from natural raw materials such as fish, soybeans, and cowhide. The product qualification rate remains stable at over 99.8%.

Nowadays, peptide factories have already broken through the single production mode. From the aquatic peptide base in Hainan to the intelligent production line in Hubei, modern peptide factories have built a full chain self-control system: the raw material end realizes "global procurement+traceability management", the production end improves efficiency by 30% through fully automated modular equipment, and the application end covers four major fields including health products, medical aesthetics, and specialty food. They are not only raw material suppliers, but also able to customize exclusive peptide formulas for customers, providing comprehensive services from research and development to production, becoming a "functional module supplier" in the health industry.

With the global peptide market expected to exceed $163 billion by 2035, peptide factories are entering a golden period of development. These production bases that adhere to technological innovation, use standardized processes to solve industry pain points, practice sustainable concepts through green production, and enable "Chinese peptides" to move from the local market to the global supply chain. From daily beauty to chronic disease management, every product from the peptide factory is bringing precision nutrition into the lives of more people.